Catalyst Wire Dossier Catalyst Wire Dossier

HEC73543

HEC73543 · Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEC73543, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML [Phase 3]

See pricing